Search

Your search keyword '"Nithya J Gogtay"' showing total 220 results

Search Constraints

Start Over You searched for: Author "Nithya J Gogtay" Remove constraint Author: "Nithya J Gogtay"
220 results on '"Nithya J Gogtay"'

Search Results

1. Has mandatory prospective registration of all studies brought about a change? A 1-year audit of studies registered in the Clinical Trials Registry of India [CTRI] before and after April 1, 2018

2. An evaluation of drug lag for new drugs approved by the Indian regulator relative to the United States, European Union, and Japanese regulatory agencies: A 15-year analysis (2004–2018)

3. A two-year evaluation of the minutes of Investigational New Drug committee meetings

4. An audit of reporting of conflict of interest policies among three stakeholders in Indian biomedical journals

5. Factors influencing recruitment and retention of participants in clinical studies conducted at a tertiary referral center: A five-year audit

6. The global initiative for asthma guidelines (2019): change in the recommendation for the management of mild asthma based on the SYGMA-2 trial – A critical appraisal

7. Recruitment and retention of the participants in clinical trials: Challenges and solutions

8. An audit of minutes of Subject Expert Committee meetings as a metric to assess the clinical research roadmap of India

9. An audit of studies registered retrospectively with the Clinical Trials Registry of India: A one year analysis

10. Current status of standardized, quality and ethical oversight of clinical research in the country: An audit of the Central Drugs Standard Control Organization (registration of ethics committees) and national accreditation board for hospital and healthcare providers (accreditation) databases

11. Investigator preparedness for monitoring and audits

12. Investigator-initiated studies: Challenges and solutions

13. Audiovisual recording of the consenting process in clinical research: Experiences from a tertiary referral center

14. A study comparing trial registry entries of randomized controlled trials with publications of their results in a high impact factor journal: The Journal of the American Medical Association

15. Valbenazine: Drug review

16. Regulatory requirements for clinical trials in India: What academicians need to know

17. Do clinical trials conducted in India match its healthcare needs? An audit of the Clinical Trials Registry of India

19. Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults

21. Age-dependent sex bias in clinical malarial disease in hypoendemic regions.

22. Evaluation of satisfaction and reasons for participation in a Covid-19 vaccine clinical trial: A single-centre, observational study

23. A Systematic Review and Meta-Analysis of the Safety of Hydroxychloroquine in a Randomized Controlled Trial and Observational Studies

24. An audit of US FDA warning letters issued to sponsors, institutional review boards and investigators over a six-year period

25. Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study

26. Has mandatory prospective registration of all studies brought about a change? A 1-year audit of studies registered in the Clinical Trials Registry of India [CTRI] before and after April 1, 2018

27. A survey of knowledge and variables influencing perceptions about clinical research: A cross-sectional study from Mumbai

28. Compliance of Mumbai-based clinical trial sites with the Quality Council of India guidelines and evaluation of the challenges faced by the investigators

29. Association of PON1 gene polymorphisms and enzymatic activity with risk of coronary artery disease

30. Bisphosphonate use and the risk of atypical fractures

31. Nose-to-Brain Delivery of Diazepam from an Intranasal Aqua-Triggered In-Situ (ATIS) Gelling Microemulsion: Monitoring Brain Uptake by Microdialysis

32. Recruitment and retention of the participants in clinical trials: Challenges and solutions

33. A randomized, controlled, equivalence study of authorized versus non-authorized deception in a model of pain following third molar extraction

34. An audit of reporting of conflict of interest policies among three stakeholders in Indian biomedical journals

35. Safety and Immunogenicity of SII-NVX-CoV2373 (COVID-19 Vaccine) In Adults in a Phase 2/3, Observer-Blind, Randomised, Controlled Study

37. Evaluation of Allergic Reactions following COVID - 19 Vaccination in Patients with Documented Allergies

38. An analysis of invitations for article submission received via emails

39. An audit of safety reporting in randomized controlled trials over a five-year period in a high impact factor journal

40. Evaluation of efficacy and safety of fosfomycin versus nitrofurantoin for the treatment of uncomplicated lower urinary tract infection (UTI) in women - A systematic review and meta-analysis

41. A comparative study to evaluate quality of data documentation between investigator-initiated and pharmaceutical industry-sponsored studies

42. Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in India

43. An audit of minutes of Subject Expert Committee meetings as a metric to assess the clinical research roadmap of India

44. Current status of standardized, quality and ethical oversight of clinical research in the country: An audit of the Central Drugs Standard Control Organization (registration of ethics committees) and national accreditation board for hospital and healthcare providers (accreditation) databases

45. Single-dose and Steady-state Pharmacokinetics of Vancomycin in Critically Ill Patients Admitted to Medical Intensive Care Unit of India

46. Pharmacokinetics of isoniazid in Indian children with tuberculosis on daily treatment

47. Steady-state Pharmacokinetics of Vancomycin in Children Admitted to Pediatric Intensive Care Unit of a Tertiary Referral Center

48. A Phase 2/3, Observer-Blind, Randomised, Controlled Study to Assess the Safety and Immunogenicity of SII-ChAdOx1 nCOV-19 (COVID-19 Vaccine) in Adults in India

49. An evaluation of drug lag for new drugs approved by the Indian regulator relative to the United States, European Union, and Japanese regulatory agencies: A 15-year analysis (2004–2018)

50. An Audit of Interim Analyses of Randomized Controlled Trials (RCTs) Published in Three High Impact Factor Medical Journals Over a Seven- year Period (2012-2018)

Catalog

Books, media, physical & digital resources